Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...
As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.
GlobalData on MSN2d
Royalty Pharma pays $250m for rights to Biogen’s lupus drugRoyalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...
US President Donald Trump kicked off his second term with a series of directives aimed at the US National Institutes of ...
In the rapidly evolving digital era, the pharmaceutical industry faces significant cybersecurity challenges, where data ...
GlobalData on MSN9d
Trump’s tariffs could strain medicine supply and drive drug costsIndustry associations react to President Trump’s tariffs and what they could mean for the pharmaceutical supply chain.
Hosted on MSN4d
National Conference on 'Pharma Innovations' Organized by Sri Aurobindo Institute of PharmacySri Aurobindo Institute of Pharmacy (SAIP), Indore, successfully hosted a National Conference on "Pharma Innovations: ...
The innovations highlighted by Sreeharsha Amarnath Rongala mark a pivotal shift in the evolution of pharmaceutical ERP ...
India's pharmaceutical exports are set to reach USD 65 billion by 2030 and USD 350 billion by 2047, placing India among the ...
Shardul Nautiyal, Mumbai Monday, February 10, 2025, 14:30 Hrs [IST] ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback